Browsing by Keyword : Bronchodilator Agents
Showing results 1 to 15 of 15
| Pub Year | | Title | AJOU Author(s) |
| 2021 | | A Randomized, Noninferiority Trial Comparing ICS + LABA with ICS + LABA + LAMA in Asthma-COPD Overlap (ACO) Treatment: The ACO Treatment with Optimal Medications (ATOMIC) Study | 신유섭 |
| 2013 | | Aspirin-intolerant asthma in the Korean population: prevalence and characteristics based on a questionnaire survey. | 남동호 |
| 2017 | | Asthma control using fluticasone propionate/salmeterol in Asian and non-Asian populations: a post hoc analysis of the GOAL study | 박해심 |
| 2011 | | Combined pharmacogenetic effect of ADCY9 and ADRB2 gene polymorphisms on the bronchodilator response to inhaled combination therapy. | 김승현, 박해심, 예영민 |
| 2015 | | Comparison of clinical efficacy and safety between indacaterol and tiotropium in COPD: meta-analysis of randomized controlled trials. | 신승수 |
| 2013 | | Differences between asthma in young and elderly: results from the COREA study. | 남동호 |
| 2011 | | Different therapeutic responses in chronic obstructive pulmonary disease subgroups. | 신승수 |
| 2019 | | Does Changing Inhaler Device Impact Real-Life Asthma Outcomes? Clinical and Economic Evaluation | 박해심 |
| 2019 | | Infantile Anaphylaxis in Korea: a Multicenter Retrospective Case Study | 이수영, 정경욱 |
| 2011 | | Predictors of pulmonary function response to treatment with salmeterol/fluticasone in patients with chronic obstructive pulmonary disease. | 신승수 |
| 2024 | | Real-world treatment trajectories of adults with newly diagnosed asthma or COPD | 박래웅, 박해심, 이영수 |
| 2010 | | Responses to inhaled long-acting beta-agonist and corticosteroid according to COPD subtype. | 신승수 |
| 2023 | | Role of club cell 16-kDa secretory protein in asthmatic airways | 박해심 |
| 2024 | | Suboptimal peak inspiratory flow rate in dry-powder inhaler users for chronic obstructive pulmonary disease in Korea | 박주헌 |
| 2018 | | Video education versus face-to-face education on inhaler technique for patients with well-controlled or partly-controlled asthma: A phase IV, open-label, non-inferiority, multicenter, randomized, controlled trial | 남동호 |
1
